‘Breakthrough’ mRNA cancer drug curbs melanoma in large trial • FRANCE 24 English
US drugmakers Merck and Moderna said Wednesday a personalised cancer treatment had shown success in reducing the recurrence of melanoma tumors in a late-stage trial hailed by experts as a “breakthrough.” Researchers have for years been trying to apply mRNA treatments against cancer, but this was the first time such a drug showed positive results in a large, late-stage clinical trial.
#cancer #melanoma #health
🔔 Subscribe to France 24 now: https://f24.my/YTen
🔴 LIVE – Watch FRANCE 24 English 24/7 here: https://f24.my/YTliveEN
🌍 Read the latest International News and Top Stories: https://www.france24.com/en/
Like us on Facebook: https://f24.my/FBen
Follow us on X: https://f24.my/Xen
Bluesky: https://f24.my/BSen and Threads: https://f24.my/THen
Browse the news in pictures on Instagram: https://f24.my/IGen
Discover our TikTok videos: https://f24.my/TKen
Get the latest top stories on Telegram: https://f24.my/TGen
1 comment
Meanwhile trump cut 500 million dollars in funding for mRNA cancer vaccine research, to the loud cheers of antivaxers. Watch him try take all the credit for any successes regardless.
Comments are closed.